Press Releases


DORAL, FL–(Marketwired – Dec 8, 2014) – In Ovations Holdings, Inc. (OTC PINK: INOH) has concluded negotiations and due diligence and has entered into a sales and marketing agreement with Regulon, Inc. (“Regulon”) for the marketing and sale of Regulon’s anti-cancer therapies. The parties will leverage INOH’s access to markets including the Caribbean in order to broaden the awareness and sale of...

Read More

DORAL, FL–(Marketwired – Jul 2, 2014) – In Ovations Holdings, Inc. (OTC Pink: INOH) (PINKSHEETS: INOH) is pleased to announce the implementation of the technology using sputum cytology for the early detection of lung cancer, a recognized laboratory procedure similar to the “Pap” test. Mel Ehrlich, Ph.D. stated, “I am pleased with the diligent efforts that In Ovations Holdings, Inc. is implementing...

Read More

DORAL, FL–(Marketwired – Jun 18, 2014) – In Ovations Holdings, Inc. (OTC Pink: INOH) (PINKSHEETS: INOH) announces that it intends to commence its early detection testing for lung cancer using the sputum cytology technology licensed from its Vice-President of Technology, Mel Ehrlich, Ph.D. Lung cancer early detection testing will be under the supervision of Dr. Osiris Madera, the Company’s new Caribbean Health...

Read More

DORAL, FL–(Marketwired – Jun 10, 2014) – In Ovations Holdings, Inc. (OTC Pink: INOH) (PINKSHEETS: INOH) has concluded negotiations for licensing sophisticated sputum cytology technology for early and pre stage detection of lung cancer from Mel Ehrlich, Ph.D., who is also an officer and director of INOH. Dr. Ehrlich has invented, patented, perfected and marketed multiple biomedical and energy efficiency technologies....

Read More

DORAL, FL–(Marketwired – May 14, 2014) – In Ovations Holdings, Inc. (OTC Pink: INOH) (PINKSHEETS: INOH) (the “Company”) announces its has bought back a total of 600 million shares of the Company’s Common Stock Shares. Those Shares have been retired back to the Companies Treasury. The Chief Executive Officer Mark Goldberg, said, “The Company is focused on several projects which are expected to...

Read More

Apr 29, 2014 OTC Disclosure & News Service In Ovations Holdings, Inc. Has Appointed Mel Ehrlich, Ph.D. as a Director and Vice-President of Technology Effective April 28, 2014 DORAL, FL–(Marketwired – Apr 29, 2014) – In Ovations Holdings, Inc. (OTC Pink: INOH) (PINKSHEETS: INOH) has appointed Mel Ehrlich, Ph.D. as a Director and Vice-President of Technology effective April 28, 2014. Dr. Ehrlich is CEO of Nano...

Read More